NovoCure
NVCR
NVCR
314 hedge funds and large institutions have $5.64B invested in NovoCure in 2022 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 90 increasing their positions, 107 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
314
Holders Change
+7
Holders Change %
+2.28%
% of All Funds
5.31%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
55
Increased
90
Reduced
107
Closed
43
Calls
$69.3M
Puts
$84.2M
Net Calls
-$14.9M
Net Calls Change
+$11.5M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$872M |
| 2 |
2
BlackRock
New York
|
$510M |
| 3 |
DTC
3
Deep Track Capital
Greenwich,
Connecticut
|
$93.2M |
| 4 |
4
Morgan Stanley
New York
|
$71.5M |
| 5 |
5
Jane Street
New York
|
$19.2M |
